Paul J. Chaplin

Planegg, BY, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

MVA-Spike encoding the A subunit of dmLT safely enhances systemic and mucosal immune responses.

MVA-Spike encoding the A subunit of dmLT safely enhances systemic and mucosal immune responses.

Journal: Frontiers in immunology

Published: December 19, 2025

Equivalence of freeze-dried and liquid-frozen formulations of MVA-BN as smallpox and mpox vaccine.

Equivalence of freeze-dried and liquid-frozen formulations of MVA-BN as smallpox and mpox vaccine.

Journal: Human vaccines & immunotherapeutics

Published: August 22, 2024

One- and Two-Dose Vaccinations With Modified Vaccinia Ankara-Bavarian Nordic Induce Durable B-Cell Memory Responses Comparable to Replicating Smallpox Vaccines.

One- and Two-Dose Vaccinations With Modified Vaccinia Ankara-Bavarian Nordic Induce Durable B-Cell Memory Responses Comparable to Replicating Smallpox Vaccines.

Journal: The Journal of infectious diseases

Published: September 27, 2022

Preclinical development of a first-in-class vaccine encoding HER2, Brachyury and CD40L for antibody enhanced tumor eradication.

Preclinical development of a first-in-class vaccine encoding HER2, Brachyury and CD40L for antibody enhanced tumor eradication.

Journal: Scientific reports

Published: August 12, 2022

A Capsid Virus-Like Particle-Based SARS-CoV-2 Vaccine Induces High Levels of Antibodies and Protects Rhesus Macaques.

A Capsid Virus-Like Particle-Based SARS-CoV-2 Vaccine Induces High Levels of Antibodies and Protects Rhesus Macaques.

Journal: Frontiers in immunology

Published: January 18, 2022

A Recombinant MVA-Based RSV Vaccine Induces T-Cell and Antibody Responses That Cooperate in the Protection Against RSV Infection.

A Recombinant MVA-Based RSV Vaccine Induces T-Cell and Antibody Responses That Cooperate in the Protection Against RSV Infection.

Journal: Frontiers in immunology

Published: December 22, 2021

Intratumoral virotherapy with 4-1BBL armed modified vaccinia Ankara eradicates solid tumors and promotes protective immune memory.

Intratumoral virotherapy with 4-1BBL armed modified vaccinia Ankara eradicates solid tumors and promotes protective immune memory.

Journal: Journal for immunotherapy of cancer

Published: December 22, 2020

Human Antibody Responses Following Vaccinia Immunization Using Protein Microarrays and Correlation With Cell-Mediated Immunity and Antibody-Dependent Cellular Cytotoxicity Responses.

Human Antibody Responses Following Vaccinia Immunization Using Protein Microarrays and Correlation With Cell-Mediated Immunity and Antibody-Dependent Cellular Cytotoxicity Responses.

Journal: The Journal of infectious diseases

Published: October 14, 2020

Broad Antibody and Cellular Immune Response From a Phase 2 Clinical Trial With a Novel Multivalent Poxvirus-Based Respiratory Syncytial Virus Vaccine.

Broad Antibody and Cellular Immune Response From a Phase 2 Clinical Trial With a Novel Multivalent Poxvirus-Based Respiratory Syncytial Virus Vaccine.

Journal: The Journal of infectious diseases

Published: April 08, 2020

A Modified Vaccine against Smallpox. Reply.

A Modified Vaccine against Smallpox. Reply.

Journal: The New England journal of medicine

Published: March 27, 2020

Phase 3 Efficacy Trial of Modified Vaccinia Ankara as a Vaccine against Smallpox.

Phase 3 Efficacy Trial of Modified Vaccinia Ankara as a Vaccine against Smallpox.

Journal: The New England journal of medicine

Published: November 14, 2019

A randomized phase II trial to compare safety and immunogenicity of the MVA-BN smallpox vaccine at various doses in adults with a history of AIDS.

A randomized phase II trial to compare safety and immunogenicity of the MVA-BN smallpox vaccine at various doses in adults with a history of AIDS.

Journal: Vaccine

Published: October 16, 2019

Showing 1-12 of 34

Last Updated: 09/26/2026